Mazzella, A.; Orlandi, R.; Maiorca, S.; Uslenghi, C.; Chiari, M.; Bertolaccini, L.; Casiraghi, M.; Lo Iacono, G.; Girelli, L.; Spaggiari, L.
How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art. Biomedicines 2024, 12, 1554.
https://doi.org/10.3390/biomedicines12071554
AMA Style
Mazzella A, Orlandi R, Maiorca S, Uslenghi C, Chiari M, Bertolaccini L, Casiraghi M, Lo Iacono G, Girelli L, Spaggiari L.
How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art. Biomedicines. 2024; 12(7):1554.
https://doi.org/10.3390/biomedicines12071554
Chicago/Turabian Style
Mazzella, Antonio, Riccardo Orlandi, Sebastiano Maiorca, Clarissa Uslenghi, Matteo Chiari, Luca Bertolaccini, Monica Casiraghi, Giorgio Lo Iacono, Lara Girelli, and Lorenzo Spaggiari.
2024. "How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art" Biomedicines 12, no. 7: 1554.
https://doi.org/10.3390/biomedicines12071554
APA Style
Mazzella, A., Orlandi, R., Maiorca, S., Uslenghi, C., Chiari, M., Bertolaccini, L., Casiraghi, M., Lo Iacono, G., Girelli, L., & Spaggiari, L.
(2024). How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art. Biomedicines, 12(7), 1554.
https://doi.org/10.3390/biomedicines12071554
